Report Detail

Pharma & Healthcare Global Heparin API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4597396
  • |
  • 02 July, 2024
  • |
  • Global
  • |
  • 130 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Heparin API market size was valued at USD 2711.4 million in 2023 and is forecast to a readjusted size of USD 5980 million by 2030 with a CAGR of 12.0% during review period.
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.
Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

This report is revolving around Heparin Active Pharmaceutical Ingredients (API).
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc.

In recent years, with the impact of African swine fever and the outbreak of COVID-19. Heparin as a resource-based industry expected to be in a state of tight supply for a period in the future, and the tight supply state may drive the sales price of heparin products to rise, the future driving force of the industry is more obvious, and the long-term profitability is more certain. The price of heparin has ushered in a major upward cycle since 2016. The main reason is that China is the main supplier of live pigs in the world. The raging African swine fever has greatly reduced the supply of live pigs, driving the price of heparin to rise sharply.

Asia-Pacific is the largest consumption place, with a revenue market share nearly 35% in 2022. Mainly China is the worlds’ largest pig production, which supplied by sufficient raw materials. Following Asia-Pacific, Europe is the second largest consumption place with the revenue market share nearly 34%.

The global key manufacturers of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and etc. In 2022, the global top five players hold a share approximately 57% in terms of revenue.
The Global Info Research report includes an overview of the development of the Heparin API industry chain, the market status of UFH (Heparin Sodium, Heparin Calcium), LMWH (Heparin Sodium, Heparin Calcium), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Heparin API.
Regionally, the report analyzes the Heparin API markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Heparin API market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Heparin API market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Heparin API industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Billion Units), revenue generated, and market share of different by Type (e.g., Heparin Sodium, Heparin Calcium).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Heparin API market.
Regional Analysis: The report involves examining the Heparin API market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Heparin API market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Heparin API:
Company Analysis: Report covers individual Heparin API manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Heparin API This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (UFH, LMWH).
Technology Analysis: Report covers specific technologies relevant to Heparin API. It assesses the current state, advancements, and potential future developments in Heparin API areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Heparin API market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Heparin API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Heparin Sodium
Heparin Calcium
Market segment by Application
UFH
LMWH
Major players covered
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heparin API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Heparin API, with price, sales, revenue and global market share of Heparin API from 2019 to 2024.
Chapter 3, the Heparin API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heparin API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Heparin API market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin API.
Chapter 14 and 15, to describe Heparin API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Heparin API
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Heparin API Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Heparin Sodium
    • 1.3.3 Heparin Calcium
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Heparin API Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 UFH
    • 1.4.3 LMWH
  • 1.5 Global Heparin API Market Size & Forecast
    • 1.5.1 Global Heparin API Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Heparin API Sales Quantity (2019-2030)
    • 1.5.3 Global Heparin API Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Shenzhen Hepalink Pharmaceutical
    • 2.1.1 Shenzhen Hepalink Pharmaceutical Details
    • 2.1.2 Shenzhen Hepalink Pharmaceutical Major Business
    • 2.1.3 Shenzhen Hepalink Pharmaceutical Heparin API Product and Services
    • 2.1.4 Shenzhen Hepalink Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
  • 2.2 Yantai Dongcheng Pharmaceutical
    • 2.2.1 Yantai Dongcheng Pharmaceutical Details
    • 2.2.2 Yantai Dongcheng Pharmaceutical Major Business
    • 2.2.3 Yantai Dongcheng Pharmaceutical Heparin API Product and Services
    • 2.2.4 Yantai Dongcheng Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
  • 2.3 Nanjing King-friend Biochemical Pharmaceutical
    • 2.3.1 Nanjing King-friend Biochemical Pharmaceutical Details
    • 2.3.2 Nanjing King-friend Biochemical Pharmaceutical Major Business
    • 2.3.3 Nanjing King-friend Biochemical Pharmaceutical Heparin API Product and Services
    • 2.3.4 Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Heparin API Product and Services
    • 2.4.4 Pfizer Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Pfizer Recent Developments/Updates
  • 2.5 Hebei Changshan Biochemical Pharmaceutical
    • 2.5.1 Hebei Changshan Biochemical Pharmaceutical Details
    • 2.5.2 Hebei Changshan Biochemical Pharmaceutical Major Business
    • 2.5.3 Hebei Changshan Biochemical Pharmaceutical Heparin API Product and Services
    • 2.5.4 Hebei Changshan Biochemical Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
  • 2.6 Bioibérica
    • 2.6.1 Bioibérica Details
    • 2.6.2 Bioibérica Major Business
    • 2.6.3 Bioibérica Heparin API Product and Services
    • 2.6.4 Bioibérica Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Bioibérica Recent Developments/Updates
  • 2.7 Qingdao Jiulong Biopharmaceutical
    • 2.7.1 Qingdao Jiulong Biopharmaceutical Details
    • 2.7.2 Qingdao Jiulong Biopharmaceutical Major Business
    • 2.7.3 Qingdao Jiulong Biopharmaceutical Heparin API Product and Services
    • 2.7.4 Qingdao Jiulong Biopharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
  • 2.8 Changzhou Qianhong Biopharma
    • 2.8.1 Changzhou Qianhong Biopharma Details
    • 2.8.2 Changzhou Qianhong Biopharma Major Business
    • 2.8.3 Changzhou Qianhong Biopharma Heparin API Product and Services
    • 2.8.4 Changzhou Qianhong Biopharma Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Changzhou Qianhong Biopharma Recent Developments/Updates
  • 2.9 Dongying Tiandong Pharmaceutical
    • 2.9.1 Dongying Tiandong Pharmaceutical Details
    • 2.9.2 Dongying Tiandong Pharmaceutical Major Business
    • 2.9.3 Dongying Tiandong Pharmaceutical Heparin API Product and Services
    • 2.9.4 Dongying Tiandong Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
  • 2.10 Opocrin
    • 2.10.1 Opocrin Details
    • 2.10.2 Opocrin Major Business
    • 2.10.3 Opocrin Heparin API Product and Services
    • 2.10.4 Opocrin Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Opocrin Recent Developments/Updates
  • 2.11 Hubei Enoray Biopharmaceutical
    • 2.11.1 Hubei Enoray Biopharmaceutical Details
    • 2.11.2 Hubei Enoray Biopharmaceutical Major Business
    • 2.11.3 Hubei Enoray Biopharmaceutical Heparin API Product and Services
    • 2.11.4 Hubei Enoray Biopharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
  • 2.12 Yino Pharma
    • 2.12.1 Yino Pharma Details
    • 2.12.2 Yino Pharma Major Business
    • 2.12.3 Yino Pharma Heparin API Product and Services
    • 2.12.4 Yino Pharma Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Yino Pharma Recent Developments/Updates
  • 2.13 Cisen Pharmaceutical
    • 2.13.1 Cisen Pharmaceutical Details
    • 2.13.2 Cisen Pharmaceutical Major Business
    • 2.13.3 Cisen Pharmaceutical Heparin API Product and Services
    • 2.13.4 Cisen Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Cisen Pharmaceutical Recent Developments/Updates
  • 2.14 Nanjing Xinbai Pharmaceutical
    • 2.14.1 Nanjing Xinbai Pharmaceutical Details
    • 2.14.2 Nanjing Xinbai Pharmaceutical Major Business
    • 2.14.3 Nanjing Xinbai Pharmaceutical Heparin API Product and Services
    • 2.14.4 Nanjing Xinbai Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
  • 2.15 Sichuan Deebio Pharmaceutical
    • 2.15.1 Sichuan Deebio Pharmaceutical Details
    • 2.15.2 Sichuan Deebio Pharmaceutical Major Business
    • 2.15.3 Sichuan Deebio Pharmaceutical Heparin API Product and Services
    • 2.15.4 Sichuan Deebio Pharmaceutical Heparin API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Sichuan Deebio Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Heparin API by Manufacturer

  • 3.1 Global Heparin API Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Heparin API Revenue by Manufacturer (2019-2024)
  • 3.3 Global Heparin API Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Heparin API by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Heparin API Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Heparin API Manufacturer Market Share in 2023
  • 3.5 Heparin API Market: Overall Company Footprint Analysis
    • 3.5.1 Heparin API Market: Region Footprint
    • 3.5.2 Heparin API Market: Company Product Type Footprint
    • 3.5.3 Heparin API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Heparin API Market Size by Region
    • 4.1.1 Global Heparin API Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Heparin API Consumption Value by Region (2019-2030)
    • 4.1.3 Global Heparin API Average Price by Region (2019-2030)
  • 4.2 North America Heparin API Consumption Value (2019-2030)
  • 4.3 Europe Heparin API Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Heparin API Consumption Value (2019-2030)
  • 4.5 South America Heparin API Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Heparin API Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Heparin API Sales Quantity by Type (2019-2030)
  • 5.2 Global Heparin API Consumption Value by Type (2019-2030)
  • 5.3 Global Heparin API Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Heparin API Sales Quantity by Application (2019-2030)
  • 6.2 Global Heparin API Consumption Value by Application (2019-2030)
  • 6.3 Global Heparin API Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Heparin API Sales Quantity by Type (2019-2030)
  • 7.2 North America Heparin API Sales Quantity by Application (2019-2030)
  • 7.3 North America Heparin API Market Size by Country
    • 7.3.1 North America Heparin API Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Heparin API Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Heparin API Sales Quantity by Type (2019-2030)
  • 8.2 Europe Heparin API Sales Quantity by Application (2019-2030)
  • 8.3 Europe Heparin API Market Size by Country
    • 8.3.1 Europe Heparin API Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Heparin API Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Heparin API Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Heparin API Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Heparin API Market Size by Region
    • 9.3.1 Asia-Pacific Heparin API Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Heparin API Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Heparin API Sales Quantity by Type (2019-2030)
  • 10.2 South America Heparin API Sales Quantity by Application (2019-2030)
  • 10.3 South America Heparin API Market Size by Country
    • 10.3.1 South America Heparin API Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Heparin API Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Heparin API Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Heparin API Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Heparin API Market Size by Country
    • 11.3.1 Middle East & Africa Heparin API Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Heparin API Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Heparin API Market Drivers
  • 12.2 Heparin API Market Restraints
  • 12.3 Heparin API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Heparin API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Heparin API
  • 13.3 Heparin API Production Process
  • 13.4 Heparin API Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Heparin API Typical Distributors
  • 14.3 Heparin API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Heparin API. Industry analysis & Market Report on Heparin API is a syndicated market report, published as Global Heparin API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Heparin API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,693.52
    4,040.28
    5,387.04
    3,194.64
    4,791.96
    6,389.28
    548,030.40
    822,045.60
    1,096,060.80
    291,450.00
    437,175.00
    582,900.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report